Fake Retatrutide Floods UK Gyms Before Approval — SkimNews
Get the Health newsletter
Daily health & science — research, biotech, public health, the studies worth knowing. Free.
- Retatrutide counterfeit vials are being sold across UK gyms, nail and beauty salons, hairdressers, social media, and even by flower sellers on the street, despite the drug still being in Phase III trials with no approval from any regulatory body — experts told the BBC this is one of the first times copycat versions of an experimental drug have spread so widely.
- Only 50% of drugs in Phase III trials in the US are eventually approved by the FDA, meaning retatrutide may never reach market, yet fake versions are already sending users to hospital with nausea, vomiting, diarrhea, and in some cases kidney failure, according to endocrinologist Prof Donal O'Shea.
- Tom Davies, a 20-year-old from Brighton, said he nearly ended up in A&E after injecting eight times the recommended dose of counterfeit retatrutide he bought from a Chinese supplier on a gym friend's recommendation, suffering 72 hours of severe diarrhea and bloating.
- Eli Lilly has reported more than 14,000 websites, advertisements, and social media posts it says are illegally marketing retatrutide, and is taking action against peptide companies, influencers, compound pharmacies, and wellness clinics while working with law enforcement.
- The MHRA has carried out raids and multiple seizures of products claiming to contain retatrutide over the past year, though illegal sales continue, with Prof O'Shea reporting some personal trainers are both supplying and injecting clients with the drug.
- Eli Lilly plans to submit its FDA application early next year, meaning even if approved, retatrutide would not be legally available in the US until end of 2027 at the earliest and in the UK potentially by 2028.
Why it matters: Consumers are injecting an unapproved Phase III drug with only a 50% chance of ever reaching market, years before any legal version could, while Eli Lilly fights 14,000+ illegal listings and hospitalizations from gym-supplied fakes continue to mount — the supply problem is outpacing both regulators and the manufacturer.
Ask SkimNews
